Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 672653, 8 pages
http://dx.doi.org/10.1155/2015/672653
Clinical Study

Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study

1Unit of Public Health, The Institute of Public Health and Clinical Nutrition, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland
2The Unit of Clinical Nutrition, The Institute of Public Health and Clinical Nutrition, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland
3Institute of Clinical Medicine, Internal Medicine, Kuopio University Hospital (KYS), P.O. Box 100, 70029 Kuopio, Finland
4Department of Clinical Chemistry, Institute of Clinical Medicine, University of Eastern Finland and Eastern Finland Laboratory Centre, P.O. Box 1627, 70211 Kuopio, Finland

Received 16 December 2014; Revised 28 April 2015; Accepted 28 April 2015

Academic Editor: Geoff Werstuck

Copyright © 2015 Tomi-Pekka Tuomainen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Khan, S. Kunutsor, O. H. Franco, and R. Chowdhury, “Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies,” Proceedings of the Nutrition Society, vol. 72, no. 1, pp. 89–97, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. N. G. Forouhi, Z. Ye, A. P. Rickard et al., “Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of Prospective studies,” Diabetologia, vol. 55, no. 8, pp. 2173–2182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. P. S. George, E. R. Pearson, and M. D. Witham, “Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis,” Diabetic Medicine, vol. 29, no. 8, pp. e142–e150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Nazarian, J. V. St. Peter, R. C. Boston, S. A. Jones, and C. N. Mariash, “Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose,” Translational Research, vol. 158, no. 5, pp. 276–281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Mitri, B. Dawson-Hughes, F. B. Hu, and A. G. Pittas, “Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial,” The American Journal of Clinical Nutrition, vol. 94, no. 2, pp. 486–494, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Dutta, S. A. Mondal, S. Choudhuri et al., “Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: An open label randomized prospective study from Eastern India,” Diabetes Research and Clinical Practice, vol. 103, no. 3, pp. e18–e23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Gagnon, R. M. Daly, A. Carpentier et al., “Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and beta-cell function in multi-ethnic vitamin D-deficient adults at risk for Type 2 diabetes: a Pilot Randomized, Placebo-Controlled Trial,” PLoS ONE, vol. 9, no. 10, Article ID e109607, 2014. View at Publisher · View at Google Scholar
  8. S. S. Harris, A. G. Pittas, and N. J. Palermo, “A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans,” Diabetes, Obesity and Metabolism, vol. 14, no. 9, pp. 789–794, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. B. Davidson, P. Duran, M. L. Lee, and T. C. Friedman, “High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D,” Diabetes Care, vol. 36, no. 2, pp. 260–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Beilfuss, V. Berg, M. Sneve, R. Jorde, and E. Kamycheva, “Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects,” Cytokine, vol. 60, no. 3, pp. 870–874, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Fève and J.-P. Bastard, “The role of interleukins in insulin resistance and type 2 diabetes mellitus,” Nature Reviews Endocrinology, vol. 5, no. 6, pp. 305–311, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Elks and J. Francis, “Central adiposity, systemic inflammation, and the metabolic syndrome,” Current Hypertension Reports, vol. 12, no. 2, pp. 99–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. E. A. Chagas, M. C. Borges, L. A. Martini, and M. M. Rogero, “Focus on vitamin D, inflammation and type 2 diabetes,” Nutrients, vol. 4, no. 1, pp. 52–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Nurmi, T.-P. Tuomainen, J. Virtanen, J. Mursu, and S. Voutilainen, “High-performance liquid chromatography and coulometric electrode array detector in serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 analyses,” Analytical Biochemistry, vol. 435, no. 1, pp. 1–9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. M. Wallace, J. C. Levy, and D. R. Matthews, “Use and abuse of HOMA modeling,” Diabetes Care, vol. 27, no. 6, pp. 1487–1495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. D. I. Phillips, P. M. Clark, C. N. Hales, and C. Osmond, “Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion,” Diabetic Medicine, vol. 11, no. 3, pp. 286–292, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Matsuda and R. A. DeFronzo, “Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp,” Diabetes Care, vol. 22, no. 9, pp. 1462–1470, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. J. K. Virtanen, T. Nurmi, S. Voutilainen, J. Mursu, and T.-P. Tuomainen, “Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland,” European Journal of Nutrition, vol. 50, no. 5, pp. 305–312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. G. Pittas, S. S. Harris, P. C. Stark, and B. Dawson-Hughes, “The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults,” Diabetes Care, vol. 30, no. 4, pp. 980–986, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A.-R. Hurskainen, J. K. Virtanen, T.-P. Tuomainen, T. Nurmi, and S. Voutilainen, “Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland,” Diabetes/Metabolism Research and Reviews, vol. 28, no. 5, pp. 418–423, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Ye, S. J. Sharp, S. Burgess et al., “Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study,” The Lancet Diabetes & Endocrinology, vol. 3, no. 1, pp. 35–42, 2015. View at Publisher · View at Google Scholar
  22. U. Salmenniemi, E. Ruotsalainen, J. Pihlajamäki et al., “Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome,” Circulation, vol. 110, no. 25, pp. 3842–3848, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Herder, E. J. Brunner, W. Rathmann et al., “Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the whitehall II study,” Diabetes Care, vol. 32, no. 3, pp. 421–423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Carstensen, C. Herder, M. Kivimäki et al., “Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: whitehall II prospective cohort study,” Diabetes, vol. 59, no. 5, pp. 1222–1227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Zittermann, S. Frisch, H. K. Berthold et al., “Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers,” The American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1321–1327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. P. J. Matias, C. Jorge, C. Ferreira et al., “Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 5, pp. 905–911, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Bucharles, S. H. Barberato, A. E. M. Stinghen et al., “Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism,” Journal of Renal Nutrition, vol. 22, no. 2, pp. 284–291, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. P. Bjorkman, A. J. Sorva, and R. S. Tilvis, “C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial,” Journal of Nutrition, Health and Aging, vol. 13, no. 5, pp. 435–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. R. von Hurst, W. Stonehouse, and J. Coad, “Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient—a randomised, placebo-controlled trial,” British Journal of Nutrition, vol. 103, no. 4, pp. 549–555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Jorde, M. Sneve, P. A. Torjesen, Y. Figenschau, L. G. Goslash;ransson, and R. Omdal, “No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects,” Cytokine, vol. 50, no. 2, pp. 175–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. A. Alvarez, S. M. Zughaier, J. Law et al., “Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease,” European Journal of Clinical Nutrition, vol. 67, no. 3, pp. 264–269, 2013. View at Publisher · View at Google Scholar · View at Scopus